期刊文献+

枳实消痞汤治疗痰湿内阻型非酒精性单纯性脂肪肝临床研究 被引量:8

Effect of Zhishi Xiaopi Tang on Non-alcoholic Fatty Liver of Phlegm-Dampness Obstruction
下载PDF
导出
摘要 目的:观察枳实消痞汤治疗痰湿内阻型非酒精性单纯性脂肪肝的临床疗效。方法:58例痰湿内阻型非酒精性单纯性脂肪肝患者随机分为治疗组(n=30)和对照组(n=28),治疗组口服枳实消痞汤12周,对照组口服多烯磷脂酰胆碱12周,观察治疗前后患者症状、血脂(TG、TC、HDL-C)、肝功能(ALT、AST、GGT)、体重指数(BMI)、腰臀比(WHR)。结果:治疗12周后,治疗组患者TG、TC、HDL-C、ALT、AST、GGT、BMI与对照组比较有统计学意义。结论:枳实消痞汤治疗可显著降低痰湿内阻型非酒精性单纯性脂肪肝患者的TG、TC、HDL-C水平,改善肝脏功能,使体重指数及腰臀围比降低,且未发现不良反应。 Objective :To observe the effectiveness of Zhishi Xiaopi tang on non-alcoholic fatty liver of phlegm-dampness. Methods: The 30patients with non-alcoholic fatty liver of phlegm-dampness were given Zhishi Xiaopi tang compared with 28 patients receiving Polyene Phosphatidylcholine for 12 weeks. Recorded before and after treatment the patients' symptoms, blood fat (TG.TC.HDL-C), liver func- tion ( ALT. AST. GGT), body mass index ( BMI), waist-to-hip ratio (WHR). Results: After 12-week treatment, the treat group showed statistically different results of TG. TC. HDL-C. ALT. AST. GGT. BMI compared with those of the control group. Conclusion: Without signs of adverse effect, Zhishi Xiaopi tang significantly lowered the levels of TG.TC.HDL-C, improved liver functions, and reduced BMI and WHR for patients with non-alcoholic fatty liver of phlegm-dampness.
作者 蒋俊民
出处 《世界中医药》 CAS 2009年第5期246-247,共2页 World Chinese Medicine
关键词 非酒精性单纯性脂肪肝/中医药疗法 枳实消痞汤 non-alcoholic fatty liver/Chinese medical therapy Zhishi Xiaopi tang
  • 相关文献

参考文献1

二级参考文献18

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 3Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 4Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 5Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 6Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 7Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 8Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.
  • 9Comar KM,Sterling RK.Drug therapy for non-alcoholic fatty liver disease.Aliment Pharmacal Ther,2006,23:207-215.
  • 10Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.

共引文献1512

同被引文献195

引证文献8

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部